BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that its Chief Executive Officer, Philip Serlin, will present a company update at the 29th Annual Oppenheimer Healthcare Conference on Tuesday, March 19, 2019 at 3:20 p.m..
March 14, 2019
· 2 min read